Cary Street Partners Investment Advisory’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
EIC
TSW
Cary Street Partners Investment Advisory's ZBH Position: Q2 2026 in Review
Cary Street Partners Investment Advisory sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 676 shares — an estimated $61.1K sold.
Cary Street Partners Investment Advisory first reported a position in ZBH in Q3 2020 and held it in 19 quarters. The position peaked at $1.14M in Q1 2024. 578 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Cary Street Partners Investment Advisory reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
- Cary Street Partners Investment Advisory sold 676 Zimmer Biomet shares in Q2 2026, an estimated $61.1K.
- Cary Street Partners Investment Advisory first reported a position in Zimmer Biomet in Q3 2020 and held it in 19 quarters.
- Cary Street Partners Investment Advisory's Zimmer Biomet position peaked at $1.14M in Q1 2024.
- 578 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.